Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Baxter
McKesson
Covington
Cipla
Queensland Health
Express Scripts
Citi
QuintilesIMS
Chinese Patent Office

Generated: January 22, 2018

DrugPatentWatch Database Preview

CEPTAZ Drug Profile

« Back to Dashboard

Which patents cover Ceptaz, and when can generic versions of Ceptaz launch?

Ceptaz is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in CEPTAZ is ceftazidime. There are seventeen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.
Drug patent expirations by year for CEPTAZ
Medical Subject Heading (MeSH) Categories for CEPTAZ

US Patents and Regulatory Information for CEPTAZ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline CEPTAZ ceftazidime INJECTABLE;INJECTION 050646-002 Sep 27, 1990 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline CEPTAZ ceftazidime INJECTABLE;INJECTION 050646-001 Sep 27, 1990 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline CEPTAZ ceftazidime INJECTABLE;INJECTION 050646-003 Sep 27, 1990 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline CEPTAZ ceftazidime INJECTABLE;INJECTION 050646-004 Sep 27, 1990 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Cantor Fitzgerald
Federal Trade Commission
QuintilesIMS
Covington
Harvard Business School
Argus Health
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot